Sequence variations of the hypervariable region of hepatitis C virus and their clinical significance

Chinese Medical Journal

Volumn 113, Issue 12, 2000, Pages 1075-1079

  Zhang, Shuncai ^a   Wang, Wei ^b   Zhou, Kang ^a   Liu, Houyu ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Hepatitis C; Hepatitis C virus hypervariable region; Reverse transcription polymerase chain reaction; Sequence analysis; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; COMPLEMENTARY DNA; VIRUS RNA;

ACUTE DISEASE; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD; FEMALE; GENETIC VARIABILITY; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; TIME; VIROLOGY; VIRUS GENOME;

ACUTE DISEASE; ADULT; AMINO ACID SUBSTITUTION; COLLAGEN TYPE IV; DNA, COMPLEMENTARY; FEMALE; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MUTATION; RNA, VIRAL; TIME FACTORS; VARIATION (GENETICS);

EID: 0034584149     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A non-B hepatitis. N Engl J Med 1989;321: 1494-1500.
2. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion non-A non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-675.
3. Houghton M. Hepatitis C virus. In: Fields BN, Kuipe DM, Howley PM, eds. Fields Virology. 3rd ed. Philadelphia: Lippincott Raven; 1996:1035-1058.
4. Ahmed M, Shikata T, Esumi M, et al. Murine humoral immune response against recombinant structural proteins of hepatitis C virus distinct from those of patients. Microbiol Immunol 1996;40:169-176.
5. Yoshioka K, Aiyama T, Okumura A, et al. Humoral immune response to the hypervariable region of hepatitis C virus dif ers between genotypes 1b and 2a. J Infect Dis 1997;175:505-510.
6. Aiyama T, Yoshioka K, Okumura A, et al. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome. Hepatology 1996;24:1346-1350.
7. Burioni R, Plaisant P, Manzin A, et al. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology 1998;28:810-814.
8. 1 proteins and the pestivirus envelope glycoproteins. Virology 1991;180:842-848.
9. Bukh J, Miller GH, Purcell RH. Genetic heterogeneity of hepatitis C virus, quasispecies and genotypes. Semin Liver Dis 1995; 15:41-63.
10. 2 binding to target cells. Proc Natl Acad Sci U S A 1996;93:1759-1763.
11. Murashima S, Sata M, Suzuki H, et al. Sequence variation of in the hypervariable region in HCV carriers with normal ALT levels: a comparison with symptomatic carriers. Microbiol Immunol 1996;40: 641-647.
12. Aiyama T, Yoshioka K, Okumura A, et al. Sequence analysis of hypervariable region of hepatitis C virus (HCV) associated with immune complex in patients with chronic HCV infection. J Infect Dis 1996;174:1316-1320.
13. Manzin A, Solforosi L, Petrelli E, et al. Evolution of hypervariable region 1 of hepatitis C virus in primary infect on. J Virol 1998;72:6271-6276.
14. Katayama Y, Tajiri H, Tadda K, et al. Follow-up study of hypervariable region sequences of the hepatitis C virus (HCV) genome in an infant with delayed anti-HCV antibody responses. Microbiol Immunol 1998;42:75-79.
15. 1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 1998;27:223-227.
16. Okamoto H, Swgiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primer: application to clinical surveys and tracing infections sources. J Gen Virol 1992;73:673-679.
17. Zhang SC, He BM, Fang GT, et al. Diagnostic value of detection of serum Type IV collagen in hepatic fibrosis. Acta Acad Med Shanghai 1998;25:306-307.
18. Enomoto E, Kurisaki M, Tanaka Y, et al. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single strand conformation polymorphism. J Gen Virol 1994;75:1361-1369.
19. Sakuma I, Enomoto N, Asahina Y, et al. Differential effect of interferon therapy on hepatitis C virus 1b quasispecies in the non-structural 5A gene. Hepatology 1997;112:A1317.
20. 1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992;16:619-624.
21. Lee JH, Strip PT, Roth WK, et al. Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism. J Med Virol 1997;53:245-251.
22. Koizumi K, Enomoto N, Kurosaki M, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995; 22:30-35.